{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:04:44Z","timestamp":1772640284240,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ministry of Science, Technology and Innovation (MOSTI), Malaysia","award":["09-02-02-009 BTK\/ER\/37\/5"],"award-info":[{"award-number":["09-02-02-009 BTK\/ER\/37\/5"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Genet Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00438-026-02370-x","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T10:37:02Z","timestamp":1772620622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and functional analysis of exonic SNPs in MMP2 and MMP3 genes as prognostic biomarkers for breast cancer patients"],"prefix":"10.1007","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6089-0111","authenticated-orcid":false,"given":"Soon-Choy","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4073-5461","authenticated-orcid":false,"given":"Fee-Wai","family":"Chin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharifah","family":"Noor Akmal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabariah","family":"Abdul Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rozita","family":"Rosli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"2370_CR1","doi-asserted-by":"publisher","first-page":"W651","DOI":"10.1093\/nar\/gkl125","volume":"34","author":"R Andreson","year":"2006","unstructured":"Andreson R, Puurand T, Remm M (2006a) SNPmasker: automatic masking of SNPs and repeats across eukaryotic genomes. Nucleic Acids Res 34:W651\u2013W655. https:\/\/doi.org\/10.1093\/nar\/gkl125","journal-title":"Nucleic Acids Res"},{"key":"2370_CR2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/1471-2105-7-172","volume":"7","author":"R Andreson","year":"2006","unstructured":"Andreson R, Reppo E, Kaplinski L, Remm M (2006b) GENOMEMASKER package for designing unique genomic PCR primers. BMC Bioinform 7:172. https:\/\/doi.org\/10.1186\/1471-2105-7-172","journal-title":"BMC Bioinformatics"},{"key":"2370_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(sici)1098-1004(1998)11:1<1::aid-humu1>3.3.co;2-e","volume":"11","author":"SE Antonarakis","year":"1998","unstructured":"Antonarakis SE, The Nomenclature Working Group (1998) Recommendations for a nomenclature system for human gene mutations. Hum Mutat 11:1\u20133. https:\/\/doi.org\/10.1002\/(sici)1098-1004(1998)11:1%3C1::aid-humu1%3E3.3.co;2-e","journal-title":"Hum Mutat"},{"key":"2370_CR4","doi-asserted-by":"publisher","first-page":"15164","DOI":"10.18632\/oncotarget.3897","volume":"6","author":"D Banik","year":"2015","unstructured":"Banik D, Netherby CS, Bogner PN, Abrams SI (2015) MMP3-mediated tumor progression is controlled transcriptionally by a novel IRF8-MMP3 interaction. Oncotarget 6:15164\u201315179. https:\/\/doi.org\/10.18632\/oncotarget.3897","journal-title":"Oncotarget"},{"key":"2370_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000108282","volume":"65","author":"I Delgado-Enciso","year":"2008","unstructured":"Delgado-Enciso I, Cepeda-Lopez FR, Monrroy-Guizar EA, Bautista-Lam JR, Andrade-Soto M, Jonguitud-Olguin G, Rodriguez-Hernandez A, Anaya-Ventura A, Baltazar-Rodriguez LM, Orozco-Ruiz M, Soriano-Hernandez AD, Rodriguez-Sanchez IP, Lugo-Trampe A, Espinoza-Gomez F, Michel-Peregrina ML (2008) Matrix metalloproteinase-2 promoter polymorphism is associated with breast cancer in a Mexican population. Gynecol Obstet Invest 65:68\u201372. https:\/\/doi.org\/10.1159\/000108282","journal-title":"Gynecol Obstet Invest"},{"key":"2370_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/humu.10152","volume":"15","author":"JT den Dunnen","year":"2000","unstructured":"den Dunnen JT, Antonarakis SE (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15:7\u201312. https:\/\/doi.org\/10.1002\/humu.10152","journal-title":"Hum Mutat"},{"key":"2370_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3892\/ijo.21.1.25","volume":"21","author":"V Djonov","year":"2002","unstructured":"Djonov V, Cresto N, Aebersold DM, Burri PH, Altermatt HJ, Hristic M, Berclaz G, Ziemiecki A, Andres AC (2002) Tumor cell specific expression of MMP-2 correlates with tumor vascularisation in breast cancer. Int J Oncol 21:25\u201330. https:\/\/doi.org\/10.3892\/ijo.21.1.25","journal-title":"Int J Oncol"},{"key":"2370_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/hmg\/ddg055","volume":"12","author":"J Duan","year":"2003","unstructured":"Duan J, Wainwright MS, Comeron JM, Saitou N, Sanders AR, Gelernter J, Gejman PV (2003) Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 12:205\u2013216. https:\/\/doi.org\/10.1093\/hmg\/ddg055","journal-title":"Hum Mol Genet"},{"key":"2370_CR9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/bcr65","volume":"2","author":"MJ Duffy","year":"2000","unstructured":"Duffy MJ, Maguire TM, Hill A, McDermott E, O\u2019Higgins N (2000) Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2:252\u2013257. https:\/\/doi.org\/10.1186\/bcr65","journal-title":"Breast Cancer Res"},{"key":"2370_CR10","first-page":"3820","volume":"8","author":"G Ghilardi","year":"2002","unstructured":"Ghilardi G, Biondi ML, Caputo M, Leviti S, DeMonti M, Guagnellini E, Scorza R (2002) A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Clin Cancer Res 8:3820\u20133823","journal-title":"Clin Cancer Res"},{"key":"2370_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10549-004-0595-6","volume":"88","author":"F Grieu","year":"2004","unstructured":"Grieu F, Wei QL, Iacopetta B (2004) Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype. Breast Cancer Res Treat 88:197\u2013204. https:\/\/doi.org\/10.1007\/s10549-004-0595-6","journal-title":"Breast Cancer Res Treat"},{"key":"2370_CR12","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s13277-013-0842-8","volume":"34","author":"E Hadler-Olsen","year":"2013","unstructured":"Hadler-Olsen E, Winberg J, Uhlin-Hansen L (2013) Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets. Tumor Biol 34:2041\u20132051. https:\/\/doi.org\/10.1007\/s13277-013-0842-8","journal-title":"Tumor Biol"},{"key":"2370_CR13","first-page":"3121","volume":"2","author":"SA Hassan","year":"2015","unstructured":"Hassan SA, Hammam O, Htwe TT, Ghanem HZ (2015) Possible diagnostic\/prognostic role of survivin and MMP3 in breast cancer disease. J Multidiscip Eng Sci Technol 2:3121\u20133127","journal-title":"J Multidiscip Eng Sci Technol"},{"key":"2370_CR14","doi-asserted-by":"crossref","unstructured":"Hunt R, Sauna ZE, Ambudkar SV, Gottesman MM, Kimchi-Sarfaty C (2009) Silent (synonymous) SNPs: should we care about them? In: Methods in Molecular Biology. pp 23\u201339","DOI":"10.1007\/978-1-60327-411-1_2"},{"key":"2370_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/14756366.2016.1161620","volume":"31","author":"A Jab\u0142o\u0144ska-Trypu\u0107","year":"2016","unstructured":"Jab\u0142o\u0144ska-Trypu\u0107 A, Matejczyk M, Rosochacki S (2016) Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem 31:177\u2013183. https:\/\/doi.org\/10.3109\/14756366.2016.1161620","journal-title":"J Enzyme Inhib Med Chem"},{"key":"2370_CR16","doi-asserted-by":"publisher","first-page":"WMC001600","DOI":"10.1152\/ajpregu.00402.2011","volume":"2","author":"AD Johnson","year":"2011","unstructured":"Johnson AD, Trumbower H, Sadee W (2011) RNA structures affected by single nucleotide polymorphisms in transcribed regions of the human genome. WebmedCentral Bioinforma 2:WMC001600. https:\/\/doi.org\/10.1152\/ajpregu.00402.2011","journal-title":"WebmedCentral Bioinforma"},{"key":"2370_CR17","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1158\/1078-0432.CCR-04-0010","volume":"10","author":"P Krippl","year":"2004","unstructured":"Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, K\u00f6ppel H, Leithner A, Wascher TC, Paulweber B, Samonigg H (2004) The 5A\/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer. Clin Cancer Res 10:3518\u20133520. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0010","journal-title":"Clin Cancer Res"},{"key":"2370_CR44","doi-asserted-by":"publisher","unstructured":"Lao C, Kuper-Hommel M, Elwood M, Campbell I, Edwards M, Lawrenson R (2021) Characteristics and survival of de novo and recurrent metastatic breast cancer in New Zealand. Breast Cancer 28:387\u2013397. https:\/\/doi.org\/10.1007\/s12282-020-01171-3","DOI":"10.1007\/s12282-020-01171-3"},{"key":"2370_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10549-006-9345-2","volume":"103","author":"H Lei","year":"2007","unstructured":"Lei H, Hemminki K, Altieri A, Johansson R, Enquist K, Hallmans G, Lenner P, F\u00f6rsti A (2007) Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression. Breast Cancer Res Treat 103:61\u201369. https:\/\/doi.org\/10.1007\/s10549-006-9345-2","journal-title":"Breast Cancer Res Treat"},{"key":"2370_CR19","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1158\/1078-0432.CCR-03-0047","volume":"10","author":"S Lepp\u00e4","year":"2004","unstructured":"Lepp\u00e4 S, Saarto T, Vehmanen L, Blomqvist C, Elomaa I (2004) A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma. Clin Cancer Res 10:1057\u20131063. https:\/\/doi.org\/10.1158\/1078-0432.CCR-03-0047","journal-title":"Clin Cancer Res"},{"key":"2370_CR45","doi-asserted-by":"publisher","unstructured":"Liang Y, Zhang H, Song X, Yang Q (2020) Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets. Semin Cancer Biol 60:14\u201327. https:\/\/doi.org\/10.1016\/j.semcancer.2019.08.012","DOI":"10.1016\/j.semcancer.2019.08.012"},{"key":"2370_CR20","doi-asserted-by":"publisher","first-page":"e31251","DOI":"10.1371\/journal.pone.0031251","volume":"7","author":"D Liu","year":"2012","unstructured":"Liu D, Guo H, Li Y, Xu X, Yang K, Bai Y (2012) Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis. PLoS ONE 7:e31251. https:\/\/doi.org\/10.1371\/journal.pone.0031251","journal-title":"PLoS ONE"},{"key":"2370_CR21","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1083\/jcb.139.7.1861","volume":"139","author":"A Lochter","year":"1997","unstructured":"Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, Bissell MJ (1997) Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol 139:1861\u20131872. https:\/\/doi.org\/10.1083\/jcb.139.7.1861","journal-title":"J Cell Biol"},{"key":"2370_CR22","doi-asserted-by":"crossref","unstructured":"Marsh S (2008) Concordance between tumor and germline DNA. In: Innocenti F (ed) Genomics and pharmacogenomics in anticancer drug development and clinical response. Humana, pp 91\u2013101","DOI":"10.1007\/978-1-60327-088-5_7"},{"key":"2370_CR23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2217\/14622416.10.3.489","volume":"10","author":"SR McWhinney","year":"2009","unstructured":"McWhinney SR, McLeod HL (2009) Using germline genotype in cancer Pharmacogenetic studies. Pharmacogenomics 10:489\u2013493. https:\/\/doi.org\/10.2217\/14622416.10.3.489","journal-title":"Pharmacogenomics"},{"key":"2370_CR24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3892\/mmr.2010.340","volume":"3","author":"FBA Munhoz","year":"2010","unstructured":"Munhoz FBA, Godoy-Santos AL, Santos MCLG (2010) MMP-3 polymorphism: genetic marker in pathological processes (review). Mol Med Rep 3:735\u2013740. https:\/\/doi.org\/10.3892\/mmr.2010.340","journal-title":"Mol Med Rep"},{"key":"2370_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1023\/A:1021371028777","volume":"77","author":"L Nakopoulou","year":"2003","unstructured":"Nakopoulou L, Tsirmpa I, Alexandrou P, Louvrou A, Ampela C, Markaki S, Davaris PS (2003) MMP-2 protein in invasive breast cancer and the impact of MMP-2\/TIMP-2 phenotype on overall survival. Breast Cancer Res Treat 77:145\u2013155. https:\/\/doi.org\/10.1023\/A:1021371028777","journal-title":"Breast Cancer Res Treat"},{"key":"2370_CR26","doi-asserted-by":"publisher","first-page":"7549","DOI":"10.1074\/jbc.M010242200","volume":"276","author":"SJ Price","year":"2001","unstructured":"Price SJ, Greaves DR, Watkins H (2001) Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene. J Biol Chem 276:7549\u20137558. https:\/\/doi.org\/10.1074\/jbc.M010242200","journal-title":"J Biol Chem"},{"key":"2370_CR27","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/00008571-200308000-00008","volume":"13","author":"JM Rae","year":"2003","unstructured":"Rae JM, Cordero KE, Scheys JO, Lippman ME, Flockhart DA, Johnson MD (2003) Genotyping for polymorphic drug metabolizing enzymes from paraffin-embedded and immunohistochemically stained tumor samples. Pharmacogenetics 13:501\u2013507. https:\/\/doi.org\/10.1097\/00008571-200308000-00008","journal-title":"Pharmacogenetics"},{"key":"2370_CR28","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.cub.2004.08.051","volume":"14","author":"MV Rockman","year":"2004","unstructured":"Rockman MV, Hahn MW, Soranzo N, Loisel DA, Goldstein DB, Wray GA (2004) Positive selection on MMP3 regulation has shaped heart disease risk. Curr Biol 14:1531\u20131539. https:\/\/doi.org\/10.1016\/j.cub.2004.08.051","journal-title":"Curr Biol"},{"key":"2370_CR29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1385\/1-59259-192-2:365","volume":"132","author":"S Rozen","year":"2000","unstructured":"Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132:365\u2013386. https:\/\/doi.org\/10.1385\/1-59259-192-2:365","journal-title":"Methods Mol Biol"},{"key":"2370_CR30","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4103\/0019-509X.52953","volume":"46","author":"FD Shah","year":"2009","unstructured":"Shah FD, Shukla SN, Shah PM, Shukla HK, Patel PS (2009) Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer. Indian J Cancer 46:194\u2013202. https:\/\/doi.org\/10.4103\/0019-509X.52953","journal-title":"Indian J Cancer"},{"key":"2370_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10549-004-0714-4","volume":"89","author":"A Sivula","year":"2005","unstructured":"Sivula A, Talvensaari-Mattila A, Lundin J, Joensuu H, Haglund C, Ristim\u00e4ki A, Turpeenniemi-Hujanen T (2005) Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer. Breast Cancer Res Treat 89:215\u2013220. https:\/\/doi.org\/10.1007\/s10549-004-0714-4","journal-title":"Breast Cancer Res Treat"},{"key":"2370_CR32","doi-asserted-by":"publisher","first-page":"e63165","DOI":"10.1371\/journal.pone.0063165","volume":"8","author":"ML Slattery","year":"2013","unstructured":"Slattery ML, John E, Torres-Mejia G, Stern M, Lundgreen A, Hines L, Giuliano A, Baumgartner K, Herrick J, Wolff RK (2013) Matrix metalloproteinase genes are associated with breast cancer risk and survival: the breast cancer health disparities study. PLoS ONE 8:e63165. https:\/\/doi.org\/10.1371\/journal.pone.0063165","journal-title":"PLoS ONE"},{"key":"2370_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/s0092-8674(00)81009-0","volume":"98","author":"MD Sternlicht","year":"1999","unstructured":"Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier J-P, Gray JW, Pinkel D, Bissell MJ, Werb Z (1999) The stromal proteinase MMP3\/stromelysin-1 promotes mammary carcinogenesis. Cell 98:137\u2013146. https:\/\/doi.org\/10.1016\/s0092-8674(00)81009-0","journal-title":"Cell"},{"key":"2370_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.47836\/mjmhs.20.1.5","volume":"20","author":"SA Suhaimi","year":"2024","unstructured":"Suhaimi SA, Chan SC, Chong PP, Chau DM, Saad N, Rosli R (2024a) Multiple SNPs downregulate gene expression of matrix metallopeptidase 2 in MCF7 breast cancer cells. Malaysian J Med Heal Sci 20:30\u201337. https:\/\/doi.org\/10.47836\/mjmhs.20.1.5","journal-title":"Malaysian J Med Heal Sci"},{"key":"2370_CR35","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.17576\/jsm-2024-5306-02","volume":"53","author":"SA Suhaimi","year":"2024","unstructured":"Suhaimi SA, Chan SC, Chong PP, Saad N, Chau DM, Rosli R (2024b) Matrix metallopeptidase 3 coding SNPs suppress cell invasion in MCF7 breast cancer cells. Sains Malays 53:1243\u20131253. https:\/\/doi.org\/10.17576\/jsm-2024-5306-02","journal-title":"Sains Malaysiana"},{"key":"2370_CR36","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/sj.bjc.6601238","volume":"89","author":"A Talvensaari-Mattila","year":"2003","unstructured":"Talvensaari-Mattila A, P\u00e4\u00e4kk\u00f6 P, Turpeenniemi-Hujanen T (2003) Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma. Br J Cancer 89:1270\u20131275. https:\/\/doi.org\/10.1038\/sj.bjc.6601238","journal-title":"Br J Cancer"},{"key":"2370_CR37","first-page":"2055","volume":"57","author":"H Ueno","year":"1997","unstructured":"Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M, Okada Y (1997) Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 57:2055\u20132060","journal-title":"Cancer Res"},{"key":"2370_CR38","unstructured":"World Health Organization (2025) Breast cancer. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer. Accessed 23 Feb 2025"},{"key":"2370_CR39","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/carcin\/bgi215","volume":"27","author":"B Xie","year":"2006","unstructured":"Xie B, Freudenheim JL, Cummings SS, Singh B, He H, McCann SE, Moysich KB, Shields PG (2006) Accurate genotyping from paraffin-embedded normal tissue adjacent to breast cancer. Carcinogenesis 27:307\u2013310. https:\/\/doi.org\/10.1093\/carcin\/bgi215","journal-title":"Carcinogenesis"},{"key":"2370_CR40","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s12885-022-09454-y","volume":"22","author":"Y Xie","year":"2022","unstructured":"Xie Y, Gou Q, Zhang Y, Xie K, Zheng D, Luo C, Suo J, Zhong X, Luo T (2022) Association between age at initial diagnosis and post-metastasis mortality among women with recurrent metastatic breast cancer in China. BMC Cancer 22:385. https:\/\/doi.org\/10.1186\/s12885-022-09454-y","journal-title":"BMC Cancer"},{"key":"2370_CR41","doi-asserted-by":"publisher","first-page":"13055","DOI":"10.1074\/jbc.271.22.13055","volume":"271","author":"S Ye","year":"1996","unstructured":"Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM (1996) Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 271:13055\u201313060. https:\/\/doi.org\/10.1074\/jbc.271.22.13055","journal-title":"J Biol Chem"},{"key":"2370_CR42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/carcin\/bgh020","volume":"25","author":"Y Zhou","year":"2004","unstructured":"Zhou Y, Yu C, Miao X, Tan W, Liang G, Xiong P, Sun T, Lin D (2004) Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes. Carcinogenesis 25:399\u2013404. https:\/\/doi.org\/10.1093\/carcin\/bgh020","journal-title":"Carcinogenesis"}],"container-title":["Molecular Genetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02370-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00438-026-02370-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02370-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T10:37:07Z","timestamp":1772620627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00438-026-02370-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2370"],"URL":"https:\/\/doi.org\/10.1007\/s00438-026-02370-x","relation":{},"ISSN":["1617-4615","1617-4623"],"issn-type":[{"value":"1617-4615","type":"print"},{"value":"1617-4623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the UKM Research and Ethics Committee (UKM FF-116-2004).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all patients enrolled in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"54"}}